Abstracts tagged "dietary supplements and epidemiologic methods"

Abstract Number: 2021 • 2015 ACR/ARHP Annual Meeting
Omega-3 Fatty Acids Are Associated with a Lower Prevalence of Autoantibody Positivity in HLA-DR Shared Epitope Positive Subjects Who Are at Increased Risk for Future RA
Ryan W. Gan¹, M. Kristen Demoruelle², Kevin D. Deane³, Michael H. Weisman⁴, Jane H. Buckner⁵, Peter K. Gregersen⁶, Ted R. Mikuls⁷, James R. O'Dell⁷, Richard M. Keating⁸, Tasha Fingerlin⁹, Gary O. Zerbe¹⁰, Michael J. Clare-Salzler¹¹, V. Michael Holers¹² and Jill M. Norris¹³, ¹Colorado School of Public Health, University of Colorado Denver, Aurora, CO, ²Rheumatology, University of Colorado School of Medicine, Aurora, CO, ³Division of Rheumatology, U Colo Denver, Aurora, CO, ⁴Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, ⁵Benaroya Research Institute at Virginia Mason, Seattle, WA, ⁶Feinstein Insititute for Medical Research, Manhasset, NY, ⁷University of Nebraska Medical Center, Omaha, NE, ⁸Division of Rheumatology, Scripps Health, La Jolla, CA, ⁹National Jewish Health, Denver, CO, ¹⁰Biostatistics and Informatics, Colorado School of Public Health / University of Colorado Anschutz Medical Campus, Aurora, CO, ¹¹Experimental Pathology, University of Florida, College of Medicine, Gainesville, FL, ¹²Rheumatology Division, Univ of Colorado School of Med, Aurora, CO, ¹³University of Colorado Denver, Aurora, CO
Background/Purpose: Studies of fish intake suggest that omega-3 fatty acids (n-3 FAs) could be protective against the development of RA. Previously, we found n-3 FAs…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].